---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-018898"
form_type: "8-K"
ticker: "HROW"
cik: "0001360214"
company_name: "HARROW, INC."
filed_at: "2024-05-13T23:59:59+00:00"
generated_at: "2026-06-02T02:07:50.208915+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Harrow Q1 revenue up 33% to $34.6M; net loss widens; FY2024 guidance at least $180M

## Summary
- Q1 revenue $34.6M (+33% YoY); GAAP net loss $(13.6M) vs $(6.6M) prior year; adj. EBITDA $0.2M vs $5.3M.
- Reaffirms FY2024 revenue guidance of at least $180M, expecting growth with back half stronger.
- VEVYE covered lives exceed 150M (from 40M); IHEEZO CMS separate reimbursement confirmed retroactive to Jan 1, 2024.
- Signed IHEEZO supply agreements with 7 multi-practice accounts; new patent through 2039. TRIESENCE PPQ batch passing preliminary assays.
- Appointed Greg DiPasquale as SVP, Head of Commercial (from Regeneron). Sold Eton shares for $5.5M cash.

## SEC filing metadata
- accession: 0001493152-24-018898
- form_type: 8-K
- ticker: HROW
- cik: 0001360214
- company_name: HARROW, INC.
- filed_at: 2024-05-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1360214/000149315224018898/0001493152-24-018898-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1360214/000149315224018898/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-018898
- JSON: https://secwatch.observer/filing/0001493152-24-018898.json
- Plain text: https://secwatch.observer/filing/0001493152-24-018898.txt

## Key facts
- Earnings Releases
  HARROW, INC. reported the first quarter ended March 31, 2024 results: revenue $34,587,000, net income (13,565,000), EPS (0.38). Guidance reaffirmed.
  - Period: the first quarter ended March 31, 2024
  - Revenue: $34,587,000
  - Net income: (13,565,000)
  - EPS: (0.38)
  - Guidance: reaffirmed
  - Result: reported results
  source text: First quarter 2024 figures of merit: For the Three Months Ended March 31, 2024 2023 Net revenues $ 34,587,000 $ 26,103,000 Gross margin 69 % 68 % Core gross margin (1) 76 % 76 % Net loss (13,565,000 ) (6,643,000 ) Core net loss (1) (9,789,000 ) (1,042,000 ) Adjusted EBITDA (1) 227,000 5,342,000 Basic and diluted net loss per share (0.38 ) (0.22 )
  evidence_url: https://www.sec.gov/Archives/edgar/data/1360214/000149315224018898/0001493152-24-018898-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.